Showing 32,181 - 32,200 results of 32,309 for search '(( significantly weaker decrease ) OR ( significantly ((better decrease) OR (between decreased)) ))', query time: 0.66s Refine Results
  1. 32181
  2. 32182

    Table_1_Potential therapeutic targets for pelvic organ prolapse: insights from key genes related to blood vessel development.XLSX by Huaye Wu (19214449)

    Published 2024
    “…Analysis of immune cell infiltration confirmed a decrease in the proportion of plasma cells in POP, and MMP19 expression showed a significant negative correlation with plasma cell numbers. …”
  3. 32183

    Image_1_Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.pdf by Qian Zhou (125859)

    Published 2022
    “…According to the current meta-analysis, which demonstrated that there was a significant decrease in waist circumference (SMD = –0.36; 95% CI: –0.59, –0.14; P = 0.002; I<sup>2</sup> = 88%), hemoglobin A1c (–0.48; –0.69, –0.27; P ≤ 0.001; I<sup>2</sup> = 94%), total cholesterol (–0.15; –0.3, –0.01; P = 0.003; I<sup>2</sup> = 94%), low density lipoprotein cholesterol (–0.42; –0.57, –0.27; P ≤ 0.001; I<sup>2</sup> = 92%), high density lipoprotein cholesterol (0.16; –0.31, –0.02; P = 0.03; I<sup>2</sup> = 81%) following resveratrol administration.…”
  4. 32184

    Table1_Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis.docx by Raquel Sainz-Amo (17279806)

    Published 2024
    “…The data indicates that 80% of patients had high (≥10 pg/ml) sNfL values at baseline. We observed a significant decrease in sNfL levels at 6 (65%, p = 0.02), 12 (70.8%, p<0.001), and 24 (78.1%, p<0.001) months. sNfL reached similar levels to HC only after 24 months of Alemtuzumab treatment. …”
  5. 32185

    Anemia and its associated factors among adult people living with human immunodeficiency virus at Wolaita Sodo University teaching referral hospital by Temesgen Anjulo Ageru (7480730)

    Published 2019
    “…Variables with <i>P-value</i> ≤0.25 in the bivariable logistic regression model were taken into multivariable logistic regression analysis along with 95% confidence interval and Odds Ratio was used to examine the association between anemia and independent variables. <i>P</i>˗value ≤ 0.05 was taken as statistically significant.…”
  6. 32186

    Data_Sheet_1_Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.pdf by Qian Zhou (125859)

    Published 2022
    “…According to the current meta-analysis, which demonstrated that there was a significant decrease in waist circumference (SMD = –0.36; 95% CI: –0.59, –0.14; P = 0.002; I<sup>2</sup> = 88%), hemoglobin A1c (–0.48; –0.69, –0.27; P ≤ 0.001; I<sup>2</sup> = 94%), total cholesterol (–0.15; –0.3, –0.01; P = 0.003; I<sup>2</sup> = 94%), low density lipoprotein cholesterol (–0.42; –0.57, –0.27; P ≤ 0.001; I<sup>2</sup> = 92%), high density lipoprotein cholesterol (0.16; –0.31, –0.02; P = 0.03; I<sup>2</sup> = 81%) following resveratrol administration.…”
  7. 32187

    Data Sheet 1_Impact of implementing a pediatric early warning system on outcomes in hematopoietic stem cell transplant units in South America and Europe.docx by Monica L. Quijano-Lievano (22808537)

    Published 2025
    “…CDE post-PEWS were less likely due to respiratory distress (38%, n = 27/71 vs. 23% n = 35/150, p = 0.0348), had fewer organ systems with dysfunction at ICU transfer (median 2 [IQR 1–3] vs. 0 [IQR 0–2], p < 0.001), and had lower PIM2, which indicates a lower severity of illness at ICU transfer (median 5.0 [IQR 1.4–7.9] vs. 1.5 [IQR 1.2–3.4], p < 0.001). There was a non-significant decrease in clinical deterioration event mortality post-PEWS implementation (24%, n = 17/71 vs. 15%, n = 22/150, p = 0.1335).…”
  8. 32188

    Data_Sheet_1_Cortical Thickness Changes After Computerized Working Memory Training in Patients With Mild Cognitive Impairment.PDF by Haakon R. Hol (6582530)

    Published 2022
    “…Structural MRI showed no group difference between the two training regimes in our MCI patients, contrary to previous reports in cognitively healthy adults. …”
  9. 32189

    Complementary interactions of cysteine and Fe(II) with 6PG. by Gabriel Piedrafita (155328)

    Published 2021
    “…Both molecules showed a noisy but significant decrease in diffusion, a further indication of Fe(II) binding. …”
  10. 32190

    Table_2_Development and Validation of a Simple-to-Use Nomogram for Predicting the Upgrade of Atypical Ductal Hyperplasia on Core Needle Biopsy in Ultrasound-Detected Breast Lesions... by Yun-Xia Huang (10502618)

    Published 2021
    “…</p>Methods<p>Two retrospective sets, the training set (n = 401) and the validation set (n = 186), from Fudan University Shanghai Cancer Center between January 2014 and December 2019 were retrospectively analyzed. …”
  11. 32191

    Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

    Published 2020
    “…Spearman correlations between the predicted and observed activity of the key BO-NN features were calculated and averaged over the six cross-validation folds. …”
  12. 32192

    Data_Sheet_1_Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.pdf by Qian Zhou (125859)

    Published 2022
    “…According to the current meta-analysis, which demonstrated that there was a significant decrease in waist circumference (SMD = –0.36; 95% CI: –0.59, –0.14; P = 0.002; I<sup>2</sup> = 88%), hemoglobin A1c (–0.48; –0.69, –0.27; P ≤ 0.001; I<sup>2</sup> = 94%), total cholesterol (–0.15; –0.3, –0.01; P = 0.003; I<sup>2</sup> = 94%), low density lipoprotein cholesterol (–0.42; –0.57, –0.27; P ≤ 0.001; I<sup>2</sup> = 92%), high density lipoprotein cholesterol (0.16; –0.31, –0.02; P = 0.03; I<sup>2</sup> = 81%) following resveratrol administration.…”
  13. 32193

    Table_1_Influence of Dietary Long-Chain Polyunsaturated Fatty Acids and ω6 to ω3 Ratios on Head Kidney Lipid Composition and Expression of Fatty Acid and Eicosanoid Metabolism Gene... by Tomer Katan (3489170)

    Published 2020
    “…The expression of pparaa was higher in the 0.3% EPA+DHA↑ω6 compared to the 0.3% EPA+DHA↑ω3 fed fish. Finally, significant correlations between head kidney fatty acid composition and the expression of eicosanoid synthesis-related transcripts (i.e., 5loxa, 5loxb, cox1, cox2, ptges2, ptges3, and pgds) illustrated the constitutive relationships among fatty acids and eicosanoid metabolism in salmon.…”
  14. 32194

    DataSheet1_Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe.docx by Jane Robertson (352569)

    Published 2021
    “…The greater consumption of Watch group agents in WHO Europe AMC Network countries suggests opportunities for improved prescribing. Significant decreases in consumption in several ESAC-Net countries illustrate the value of sustained actions to address antimicrobial resistance.…”
  15. 32195

    DataSheet1_Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe.docx by Jane Robertson (352569)

    Published 2021
    “…The greater consumption of Watch group agents in WHO Europe AMC Network countries suggests opportunities for improved prescribing. Significant decreases in consumption in several ESAC-Net countries illustrate the value of sustained actions to address antimicrobial resistance.…”
  16. 32196

    Table_2_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

    Published 2023
    “…As the secondary endpoints, the changes in fasting apoB-48 in PEMA and OMEGA-3 were −3.10 μg/ml (−5.63 to −1.87) and −0.90 μg/ml (−2.95 to 0.65) (P < 0.001), respectively. Greater decreases with significant differences in the percentage changes in TG, remnant lipoprotein cholesterol, apoC-III, fasting plasma glucose, alanine aminotransferase, gamma-glutamyl transpeptidase, and alkaline phosphatase were observed in PEMA, compared with OMEGA-3. …”
  17. 32197

    DataSheet1_Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe.docx by Jane Robertson (352569)

    Published 2021
    “…The greater consumption of Watch group agents in WHO Europe AMC Network countries suggests opportunities for improved prescribing. Significant decreases in consumption in several ESAC-Net countries illustrate the value of sustained actions to address antimicrobial resistance.…”
  18. 32198

    Table_2_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

    Published 2023
    “…As the secondary endpoints, the changes in fasting apoB-48 in PEMA and OMEGA-3 were −3.10 μg/ml (−5.63 to −1.87) and −0.90 μg/ml (−2.95 to 0.65) (P < 0.001), respectively. Greater decreases with significant differences in the percentage changes in TG, remnant lipoprotein cholesterol, apoC-III, fasting plasma glucose, alanine aminotransferase, gamma-glutamyl transpeptidase, and alkaline phosphatase were observed in PEMA, compared with OMEGA-3. …”
  19. 32199

    Data_Sheet_1_Light at night exposure and risk of breast cancer: a meta-analysis of observational studies.doc by Zining Luo (17523543)

    Published 2023
    “…The overall meta-analysis demonstrated a significant association between exposure to LAN and risk of breast cancer (RR = 1.12; 95% CI: 1.06–1.17; I<sup>2</sup> = 31.3%, p < 0.001). …”
  20. 32200

    Table_1_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

    Published 2023
    “…As the secondary endpoints, the changes in fasting apoB-48 in PEMA and OMEGA-3 were −3.10 μg/ml (−5.63 to −1.87) and −0.90 μg/ml (−2.95 to 0.65) (P < 0.001), respectively. Greater decreases with significant differences in the percentage changes in TG, remnant lipoprotein cholesterol, apoC-III, fasting plasma glucose, alanine aminotransferase, gamma-glutamyl transpeptidase, and alkaline phosphatase were observed in PEMA, compared with OMEGA-3. …”